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Abstract--Three ecological models describing independent subpopulation growth, interactive competition 
for shared resources and endomitotic or inductive emergence of one population from the other are 
analyzed in an effort o describe the effects of environmental stress on the dynamic omposition of artificial 
heterogeneous tumors (human colon adenocatonoma cells) treated with Mitomycin C. A mathematical 
relationship for the dynamic omposition of a heterogeneous tumor is derived for each model, and from 
these derived systems, isoclines for the composition trajectories are identified. Actual compositional 
dynamics of neoplasms perturbed from equilibrium by a therapeutic agent which displays differential cell 
kill are compared to similar dynamics of tumors which are mechanically displaced from equilibrium within 
the context of these theoretical structures. Each parameter in each model is identified with specific 
environmental stress effects, and the effects exerted upon the isoclines are identified. The biological 
mechanisms associated with theoretical stresses are discussed. 
INTRODUCTION 
Because different subpopulations within a tumor display a range of sensitivities to any cytotoxic 
intervention, the inherent cellular heterogeneity of neoplasms fundamentally affects the ultimate 
success of cancer therapy [1]. Consequently, in this paper we investigate the effects of therapy upon 
the ultimate population mix of a heterogeneous tumor, and ask whether these responses can be 
exploited for therapeutic advantage. 
The heterogeneous tumor system, DLD-1, has been described in great detail [2-5]. Briefly, 
a human colon carcinoma biopsy specimen displaying histological heterogeneity was obtained 
from a patient. The parent cell line, DLD-1, consists of two morphologically and karyo- 
typically distinct subclones in a naturally occurring 10:90 ratio. These subelones have been 
termed clone A (poorly differentiated, 10%) and clone D (moderately differentiated, 90%). 
Differential response to a number of therapeutic agents has been observed for each clone 
in vitro [6-10]. 
Still, the range of effects exerted by therapeutic agents on heterogeneous tumors in vivo is as 
yet poorly understood. Clearly, differential cell kill and initiation of selective pressures under 
which resistant subpopulations may emerge represent major dynamics of therapy. Of equal concern 
may be the induction of resistant populations by the agent itself [11-13]. However, some agents 
may also alter the micro-environment i  which the tumor is evolving, and thus exert a series of 
effects upon the dynamics of subpopulation growth which have yet to be fully identified or 
quantified. 
Therefore we undertook these theoretical studies to gain an insight into the types of dynamics 
one might observe in an evolving neoplasm which has been displaced from equilibrium by 
differential cell kill. We base our study on three micro-ecologies which describe subpopulation 
dynamics [14]. To test our models, we require two types of measurements from our experimental 
system: (1) volumetric data as a function of time; and (2) a time-dependent representation f tumor 
composition so that we can define the parameterization of competition dynamics between 
subpopulations. Using these data, we describe the types of damage a therapeutic agent may inflict 
on tumor populations vis-d,-vis the environment. 
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THE MODELS 
If we base our analyses on the potential dynamics observed in the DLD-I tumor system, three 
models describing possible micro-environments in which heterogeneous tumors may evolve 
present hemselves (described in detail in Ref. [14]). Let D(t) and A(t) represent the sizes of the 
clone D and clone A populations, respectively, at time t. The models under consideration are nested 
in that each new model represents a generalization of the dynamics described in the previous 
environment. The first model describes an ecology that represents non-interactive growth in a static 
environment: 
and 
D' = rt D(1 - D/N)  
A' = r2A(1 - A/M) .  (1) 
In this model, two subpopulations of cancer cells grow independently of each other and do not 
compete for common resources. Their ultimate growth is determined purely by the carrying 
capacities of the host environment (N and M) for each type of tumor cell. 
The second model describes an ecology in which the two cell types compete for common, vital 
resources. The interactive competition is described by 
and 
D' = rl D(1 - D/N - ),i A) 
A' = r2A(l - A/M - 22D). (2) 
The carrying capacities, M and N, in this model are the same as those defined in the 
non-interactive model, and the constants 21 and ),2 represent the "weight of competition" one 
subpopulation exerts on the other. The equilibrium dynamics for this classical competition model 
are described by Waltman [15]. 
The third model presented in this paper is an extension of the work presented by Jansson and 
Revesz [16]. This model, termed the JRE model, describes a competitive ecology with the added 
dynamics that one type of cell emerges from the other due to either mutation ("endomitosis" in 
the Jansson and Revesz papers) or induction: 
D' = rl D(I - D/N - ),1 A) - pD 
and 
A' = r2A(1 - A/M - ),2D) + pD. (3) 
The carrying capacities and interactive terms in this model are the same as those defined by the 
classical competition model. The transition rate between populations i the constant, p. Typically, 
mutation rates that describe the emergence of drug resistant subpopulations in sensitive tumor 
populations are rather small. Goldie and colleagues [17-20] estimate values for p near 10 -6. 
However, if one population can be induced to transform into the other (e.g. induction of drug 
resistant subpopulations via the p-glycoprotein mechanism [11-12]), the values of p may be quite 
large. 
COMPOSITION 
By using these three models we can generate subsidiary models which describe the dynamics of 
subpopulation composition. In general, the model for the composition function can be derived as 
follows. Let C(t )  = D( t ) / (D( t )  + A(t)), with D(t) and A(t) as defined above. Then differentiation 
of C yields, 
C' = [D/ (D  + A)]' 
= [D'(D + A) - (D' + A')D]/(D + A) 2 
= [D'(1 - C)  - A 'C] / (D  + A).  (4) 
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By substituting the appropriate model [system (1), (2) or (3)] into equation (4), we can 
derive expressions for C' in terms of C, A and D, and the model parameters. In the 
following sections, we derive the three nested models for C', and for each we discuss the locus of 
points which define C '= 0 (i.e. the 0 isocline). At these loci the slope of C(t )  is zero and the 
dynamics of the subpopulation compositions are either local maximums, local minimums, or 
inflection points. 
Independent growth 
Substituting the model equations given in system (1) into equation (4), we derive 
C' = C(I - C)[rl (1 - D/N)  - r2(1 - A/M)]. (5) 
Because C is entirely contained in the interval [0, 1], C (1 -  C)/>0. C = 0 corresponds to 
complete xclusion of the D subpopulation, i.e. a tumor that is pure A. Growth is then completely 
described by the logistic equation for the growth of A cells. Similarly, if C = 1, the tumor is 
composed strictly of D cells. A simple analysis of the system [14] shows that the origin is a repeller 
and that competitive xclusion is impossible. Therefore, for a heterogeneous tumor, we are only 
interested in the interval (0, 1) for C. The locus of points at which C' = 0 (i.e. the 0 isocline) is 
strictly determined by the equation 
r, (1 - D/N)  -- rE(1 - A/M)  = O. (6) 
This is a linear function of D in the A-D plane: 
D = [r2N/r I M]A + N(rl  - r2)/rl. (7) 
The slope of the line in the A-D plane, [r2N/rlM], is always positive, and the intercept of the 
line is given by N(r~ - r2)/r~. If r~ = r2, the intercept is the origin. If the trajectory (A(t), D(t)) 
crosses this line and if the composition achieves a local maximum or minimum, we say that the 
trajectory exhibits "humped dynamics". 
Since this type of ecology must attain an equilibrium point at (M, N), the final composition of 
the tumor must be N/(N  + M) .  The slope of the composition function asymptotically approaches 
zero at the equilibrium point (i.e. the point is globally stable), and thus the C '= 0 isocline 
passes through the point (M, N). The line given by equation (7) must traverse the "growth region" 
in the A-D plane, i.e. the rectangle bounded by the axes, and the lines A = M and D --- N, and 
if the trajectory (A(t), D(t)) does not cross it, we say that it exhibits "asymptotic dynamics" (see 
Fig. 1). 
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Fig. 1. Graphs of composition vs time exhibiting either "humped ynamics" or "asymptotic dynamics". 
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Classical competitive interactions 
Substituting system (2) into equation (4) we derive the composition dynamics for a micro-ecology 
that describes two populations competing for shared resources. The equation for C'(t) is given by 
C'(t) = C(1 - C)Jr, (1 - D/N - 2, A) - r2(1 - A/M - 22D)]. (8) 
Because C is constrained to the interval [0, 1], the slope of C(t) is zero only when C = 1, C = 0 
or rl (1 -D /N  -21A) -  r2(1 - -A/M -22D)  = 0. As in the non-interactive ecology, the origin is a 
repeller. Therefore we will constrain our analyses to regions of the A-D plane in which at least 
one of the populations i non-negative. However, the population dynamics described in this ecology 
allow for competitive xclusion [15]. In the open interval (0, 1), C(1 - C) is strictly positive, and 
the isocline is determined by rl(1 - D/N - 21A) -- r2(1 -- A/M - 22D ). This equation defines a 
linear function of D in the A-D plane, 
D = [r2/M - r121] A + rl - r2 (9) 
[rt/N - -  r222] [rt/N - -  r222] " 
Note: if 2i = 0, equation (9) degenerates to equation (7), as would be expected for nested models. 
The critical points defined by this ecology include the origin, two competitive xclusion points 
(M, 0) and (0, N) and an equilibrium point (A*, D*) [15]. Using the Dulac criterion, Waltman rules 
out periodic trajectories about critical points as viable dynamics in the non-negative r al quadrant. 
The dynamics of the ecology in asymptotically attaining one of these critical points determines the 
overall dynamics of the composition. For any given set of parameter values, Waltman shows that 
one of the non-zero critical points is asymptotically stable. The asymptotic stability of the critical 
point insures that the line, D(A), as defined by equation (9), passes through it in the phase plane. 
If the A population is excluded, i.e. if a pure D tumor emerges from a heterogeneous implant, two 
C' = 0 lines intersect at (0, N). The first line is the axis itself. The second line is defined by equation 
(9). If the slope of the second line is positive, then the line will not traverse the growth region, and 
all the composition trajectories will exhibit "asymptotic dynamics" in this ecology. If the slope of 
the second line is negative, then the line will pass through the growth region, and "humped 
dynamics" are possible. 
Similarly, if the population exhibits competitive xclusion of the D population, i.e. a pure A 
tumor emerges, the two C' = 0 lines intersect along the A-axis at M. Again if the slope of the second 
line is positive, the line cannot cross the growth region and all trajectories exhibit "asymptotic 
dynamics". In this case, the line must have a negative D-intercept, and therefore, one can conclude 
that (r 2 - - r t )  has opposite sign from ( r j /N -  r222). If the slope of the second line is negative, the 
D-intercept must be positive, and the line must traverse the growth region, and again "humped 
dynamics" are a possibility. 
If an equilibrium point is established, then the line C' = 0 in the A-D plane will always pass 
through the growth region, and again, "humped ynamics" are possible. We discuss the significance 
of these types of dynamics with special emphasis on the effects environmental damage induced 
during chemotherapy. 
The extension of the JRE model 
Jansson and Revesz [16] describe a tumor ecology in which two subpopulations complete for 
common resources. However, their model differs from the classical competitive interaction model 
by a term which describes the emergence of one population from the other. Evidence for this type 
of dynamic in the DLD-1 system exists (J. T. Leith, personal communication). However, as noted 
above, the inductive mergence of multi-drug resistant subpopulations from initially sensitive cells 
could just as easily be modeled using JRE model ecology. 
By substituting system (3) into equation (4), we derive 
C'(t) = C(1 - C)[r~ (1 - D/N - 2~ A) - r2(l -- A/M - 22D)] - C2p. (10) 
In this model, the values of C are again constrained to the closed interval [0, 1]. If we assume that 
A cells emerge from D cells, the omega limit set for this model includes the origin, the competitive 
exclusion point of the D population, (M, 0), and an equilibrium point, (A*, D*) [14]. An analysis 
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of the model ecology shows that the origin is a repeller. We therefore constrain our analysis to 
dynamics in which at least the A population is not extinct. Then the solution of the equation C' = 0 
is given by C = 0 and, when C ~ 0, the solution of 
(1 -- C)[rl(1 - DIN - 21A) - r2(l -- AIM - ;t2D)] - Cp = 0. (11) 
Solving in terms of A and D, let (1 - C) = A/(A + D). Then we derive 
( r2 /M - rt 21 )A 2 + (r2),2 - rl/N)AD + (rl - r2)A - pD = 0. (12) 
To verify the nesting of the two models, note that equation (12) is solved by equation (9) when 
p = 0, and that the classical model is in fact a special case of the extended JRE model. 
Solving equation (12) for D in terms of A yields 
D=[r2 /M- r I~ , I ]A+ r l - r2 -P  [ r2 /M- r121]p  
[ r l /N  - -  r222] [ r l /N  - r222] [rl/N - r:22] 2 
+ { [rl - r2 - p]/[rl/N - r 222 ] - J r2 /M - r121 ]P/[rt/M - r225 ]2} p (13) 
( r l /N  - r222)A + p 
Again, if p = 0, equation (13) degenerates to the line described in equation (9). 
The linear coefficients of A in equations (9) and (13) are identical. The difference in the intercept 
terms is given by 
p p( r2 /M - r121) 
+ (14) 
( r l /N  - R222) ( r l /N  - -  r222) 2 " 
As A increases toward values of M, the final term in equation (13) decreases and contributes 
little to the shape of the line. Though A cells cannot be competitively excluded in this particular 
model, we have shown in prior work [14] that by setting the competition parameters to levels that 
should exclude A, we can establish equilibria as near to the axis as we want. We termed these 
dynamics "asymptotic exclusion", and recognize that deterministic differential equation systems are 
inadequate tools in describing them. However, to complete these analyses, we must consider the 
case when the size of the A population is near zero. 
If we let A approach zero, the final term in equation (13) approaches 
(rl - r2 - p) (r2/M - rj ;q )p 
(r I/N - -  r2,~,2) ( r l /N  - -  r2,~.2) 2 " (15) 
The effect of small A is exerted exclusively on the intercept of the linearized isocline. 
EXAMPLE DYNAMICS 
Obviously, the primary effect of therapy in any tumor population is cell kill. This effect is akin 
to herd thinning in a macro-ecological system. However, during cancer chemotherapy, subsidiary 
damage inflicted on the environment by therapeutic agents, alteration of interspecific competition 
rates and disruption of important intraspecific growth dynamics may also accrue. These effects may 
extend beyond the simple selection of resistant subpopulations. Induction of multi-drug resistant 
subpopulations, the establishment of new population equilibria due to realignment of competition 
parameters and changes in the host's ability to carry the tumor cells may be fundamental to the 
treatment of heterogeneous tumors. 
To understand the effects of these environmental stresses more completely, we use the three 
models developed above to analyze volumetric and compositional time courses from artificial 
heterogeneous tumors (AHTs) implanted in nude mice [20]. Control populations were not treated 
with drugs, while test populations received a single dose of Mitomycin C when the tumor achieved 
a size of 500 mm 3. The differential responses to Mitomycin C displayed by D and A clones have 
been verified by Leith et  al. [20]: A cells are approx. 40 times more sensitive to the killing effects 
of this drug than are D cells at the in v ivo dose level of 5 #g/g. 
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Fig 2. Typical volumetric regrowth curve for DLD- I  tumor implants after single dose Mitomycin C 
therapy. Derived from Leith et al. [20]. 
Figure 2 represents a typical volumetric regrowth curve for tumors treated with Mitomycin C. 
The delay in regrowth is approx. 1 week, and the projected carrying capacity of the host for the 
tumor is between 20 and 30% of the original size [20]. Figure 3 represents the actual experimental 
dynamics observed for the composition of two different AHTs (originally 90% A: 10% D and 90% 
D:10% A) treated with Mitomycin C. These tumors display the composition dynamics which are 
"humped" as predicted for trajectories which cross the C'= 0 isocline in the A-D plane. 
One important question is, what effect is exerted on the C'= 0 isocline and the population 
trajectories by changes in each of the model parameters? To that end, we have simulated tumor 
growth within each micro-ecology. 
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Fig. 3. Tumor composition vs time after perturbation (treatment with Mitomycin C) when the tumor 
had achieved a volume of 55 mm 3. Panel A shows the result of perturbation when the AHT was 
initially established at approx. 95 D:5% A. Panel B shows the result when the AHT was established at 
5% D:95% A. Reproduced by permission of Cancer Research. 
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Fig. 4. Result of differential repopulation rates on tumors growing in a independent micro-ecology. Panel 
A shows the original 0isoeline (C~) and the offset isoeline (C~) and a sample trajectory simulated under 
the repopulation conditions. The trajectory crosses the new isocline at day 14.5. Panel B shows the 
composition vstime curve for the trajectory given in panel A. The trajectory displays humped ynamics 
with a minimum at day 14.5. 
155 
Suppose drug treatment results in differential repopulation rates that reflect he differential cell 
killing as originally observed. Suppose also that the drug does not affect the carrying capacity of 
the host or the interspecific competition rates of the two populations. Without loss of generality, 
we can assume that the drug affects r2 in the simulated tumor. 
Simple inspection of equation (7) shows that the slope of the isocline in a non-interactive 
environment increases proportionally with r2. Because the isocline must pass through the point 
(M, N), the intercept must decrease as well. In Fig. 4A we show the original and the modified 
isoclines (C~ = 0, where the subscript "s" represents steady state, and Ct= 0, where the subscript 
"t"  represents treated tumors), as calculated from equation (7). A simulated trajectory is plotted 
on the graph. The time-dependent composition function is plotted in Fig. 4B. As r: increases, the 
trajectory becomes "flatter" in that the A cells will grow faster than the D cells. The limiting 
trajectory as r2 ~ oo is the union of the A-axis and the line A = M. Therefore, as r2 ~ oo a l l  
trajectories will cross C~ = 0, and all will display humped dynamics. 
Similar analyses were performed for the classical competition model. The calculation of the C~ 
and C~ isoclines are given in Fig. 5A. A simulated trajectory is also plotted in Fig. 5A, and the 
time-dependent composition curve is plotted in Fig. 5B. The dynamics of equation (9) are not as 
easily characterized as those in equation (7). However, because the ultimate quilibrium mix in the 
competitive micro-ecology is a function of the carrying capacities and competition parameters [15], 
changing the repopulation rates for either population does not affect the character of the 
equilibrium point. Therefore, an ecology that originally attains a 90:l0 mix must return to the 
90:l0 equilibrium point no matter what the r,. values are. The only discernible ffect of changes 
in theise parameters i exhibited as either humped or asymptotic dynamics of the composition. 
It is important o note, that DLD-1 tumors displaced from equilibrium mechanically, i.e. one 
in which the original implant is a 50:50 mix, have displayed asymptotic dynamics for the 
composition [5]. 
Michelson et  al .  [14] show that the equilibrium point in the JRE micro-ecology is the 
simultaneous solution (if it exists) of 
(r~ - p)D - ( r l /N )D 2 - r~ 21DA = 0 
and 
r2A(1 - A/M)  - r222DA + pD = 0. (16) 
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Fig. 5. Result of differential repopulation rates on tumors growing in a competitive micro-ecology. Panel 
A shows the original 0 isocline (C~) and the offset isocline (C~) and a sample trajectory simulated under 
the repopulation conditions. The trajectory crosses the new isocline at day 17. Panel B shows the 
composition vs time curve for the trajectory given in panel A. The trajectory displays humped dynamics 
with a minimum at day 17. 
If we constrain our analysis to compositional equilibria [solutions to equations (16)], then D # 0. 
Then, after dividing the first equation by D, the first simultaneous condition the equilibrium 
solution must satisfy is 
A = ( -  1/N2~)D + (r~ - p)/r[ 2,. (17) 
The second simultaneous condition the equilibrium solution must satisfy is described by 
P(r2 -- p/M,~2) 
D = ( -  1/MA2)A + [r2 - p/M22]/r222 + [r-~-]~A- _ - r~  p • (18) 
When p = 0, equations (17) and (18) degenerate o the classical equilibrium conditions for the 
two competitive populations [15]. When p is very small (e.g. 10-6), the appropriate parts of the 
second and third terms of equation (18) are "near enough" to zero, that the end-population mix 
is not appreciably affected by changes in the ri. However, as p increases, the solution to the 
equilibrium conditions can vary significantly with the r~, and, in fact, can yield anomalous results 
for the end-equilibrium ix [21]. In that study, Michelson and Leith showed that increasing r2 can 
decrease the end-population mix of the A population as a function of the transition (mutation) 
rate, p. 
Now suppose that cytotoxic therapy results in an impaired capacity for the host to carry an 
equivalent umor burden. In Mitomycin C treated neoplasms regrowth curves of two AHTs 
indicate that the asymptotic total volumes of the regrowing tumors are between 20 and 30% of 
the controls [20]. Therefore, as a first approximation, we have assumed that the total tumor burden 
a host can carry is decreased to 30% of normal, and that the damage is non-differential, i.e. each 
individual carrying capacity is decreased by 30%. 
Inspection of equation (7) shows that treatments which decrease the carrying capacities for each 
population by the same amount merely scale the growth region and its isocline. The slope of the 
new isocline is the same as the slope of the original, and the intercept is reduced in magnitude by 
the fraction of decrease suffered by each population. The asymptotic tumor size is reduced by the 
same fraction, but the end-equilibrium ix stays the same as that originally observed in the tumor. 
In fact, the only way to alter the end-populatoin mix for the non-interactive micro-ecology is to 
differentially change the host's ability to carry the different populations. 
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In the classical competition model, the equilibrium mix is strictly determined by M2 2 and N2, 
[15]. Waltman shows that if the products of carrying capacities and competition terms are < 1 for 
each population, the tumor will attain an equilibrium point. The mix at the equilibrium point is 
the solution of 
and 
D + 21NA = N 
A + 22MD + M. (19) 
Because we assume therapy damages a host's capacity for carrying a tumor, in these analyses 
we only consider decreases in M and N. Therefore, treatment within an ecology that had achieved 
an equilibrium must  result in a new micro-ecology that defines an equilibrium point as one of its 
critical points. If we assume that the cytotoxic agent acts non-differentially on the host's ability 
to carry each type of tumor cell, and if we assume that M # N, then the resulting equilibrium point 
in the treated milieu will likely be of a different mix than the original, and the effects on the isocline 
given by equation (9) are not obvious. 
To gain a better insight into this environmental effect, we simulated the growth of a 
heterogeneous tumor growing within a competitive micro-environment i  a host which can carry 
only 30% of its original tumor burden. The growth region was decreased appropriately. In these 
simulations, the original isocline was defined by the line D = 13.95A- 1295.5. The new isoeline 
is defined by the line D = 1.59A- 118.0. The original equilibrium mix was established at 92% 
D: 8% A. By holding the competition parameters fixed to their original values, the treated 
environment yields a new equilibrium given by a 61% D:39% A mix. 
DISCUSSION 
Leith et al. [20] showed that tumors in mice treated with Mitomycin C exhibit typical regrowth 
dynamics (see Fig. 2) and that the carrying capacities of the hosts for the tumors are 20-30% of 
those originally observed in the control populations. A latency period of approx. 1 week was 
observed from drug administration to the point at which regrowth begins. The compositions of 
two different AHTs were followed throughout the regrowth period, and each displays humped 
dynamics while achieving new end-population mixes. 
The effects of environmental stress induced by treatment with Mitomycin C in our experimental 
system suggest that the simple dynamics exhibited in a macro-ecological model for herd thinning 
can not sufficiently describe the regrowth dynamics of heterogeneous tumors in the therapeutic 
milieu. The observation that mechanical displacement from equilibrium results in asymptotic 
dynamics for the composition, while chemical displacement from equilibrium results in humped 
dynamics uggests that environmental stress may play an important role in our understanding of
population dynamics in heterogeneous tumors. 
Each parameter in the ecological models must represent some biological mechanism(s) in the 
heterogeneous milieu. For example, an explanation for increased rates of repopulation i  treated 
neoplasms is recruitment from non-proliferative compartments. In our model tumor system, 
Mitomycin C acts differentially in killing type A cells. In fact, Leith and colleagues [20] show that 
in r ive cell kill for type A cells is 40 times higher than for type D cells at a dose of 5 #g/g animal 
body wt. If the therapeutic effects are exerted ifferentially, recruitment from the non-proliferative 
compartments may also be expressed ifferentially, yielding disparate parameter estimates for 
the rs, and results similar to those seen in Figs 4 and 5. Such differential recruitment has also 
been observed experimentally in heterogeneous mouse mammary carcinomas by Wallen and 
colleagues [22]. 
Changes in tumor carrying capacities may result from damage incurred by the host. The ability 
to carry a tumor may be impaired ue to local damage in underlying stroma or microvasculature, 
or to systemic damage in the host's ability to generate vital resources, metabolites, growth factors 
etc. If one were to posit that neoplastic ell populations do not  compete for shared resources [i.e. 
system (1)], then changes in the end population mix (as observed by Leith in the Mitomycin-treated 
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AHTs) would require that Mitomycin C inflicts differential damage to the host's ability to carry 
different ypes of cancer cells. If, on the other hand, one considers growth in the two competitive 
micro-ecologies, the equilibrium mix will depend intimately on both the carrying capacities and the 
competition parameters of the model. 
We are limited by our technologies to measuring the volumetric and compositional time courses 
of growing tumors. From these data we can estimate the growth parameters, ri, N and M for each 
population independently, and we can extrapolate these values to describe competitive growth 
within an AHT. However, at the present ime, there is no explicit way to measure the weight of 
competition one population exerts upon the other. Rather, we derive implicit values for the Ai which 
mimic the equilibria dynamics observed in viva. I f  therapy were to induce changes in the 
competition parameters one can only speculate as to the underlying biological mechanisms 
being affected. For example, suppose one population is better equipped to compete in a local 
micro-environment which is intermittently hypoxic. Then damage to stroma or oxygen transport 
mechanisms may confer a competitive advantage upon that population. Biochemical changes in 
the local micro-environment, including changes induced in metabolite transport (e.g. an induction 
similar to the induction of p-glycoprotein) could clearly affect the interspecific ompetition rates 
within the theoretical models. Leith and colleagues [20] have shown that differential cell kill of 
Mitomycin C will cause AHTs that were originally 90% A: 10% D to reach a final asymptotic 
composition of 18% A:82% D. The composition kinetics exhibit humped dynamics, and the 
carrying capacity of the host is approx. 30% of that observed in the control mice. Of  note is the 
fact that the new trajectories pass through the formerly stable 90% D:10% A composition. Using 
only the time course data for the volumetrics to establish the carrying capacities for each population 
and fixing the competition parameters at their control (original) values, our models predict an 
end-population mix of 60% A: 40% D. Therefore, if we were to posit that heterogeneous tumors 
grow in a competitive milieu, our models would suggest that environmental stress exerts a 
significant influence on the competitive interaction rates as well as the carrying capacities. 
We should temper our speculations based on these models by noting that they are themselves 
a first approximation to the theory of micro-ecology in a heterogeneous tumor. For example, we 
have assumed that the damage induced by therapy in a host is itself permanent. I f the environment 
is resilient, i.e. if the host can repair the damage it has suffered (e.g. due to Mitomycin C) then 
the extrapolated carrying capacities for the tumor are underestimates of the true carrying capacities 
in the hosts. In such a situation, the environment i self is evolving, and the effects on long-term 
growth cannot yet be predicted. Still, our qualitative studies suggest hat cytotoxic therapy may 
effect the environment in which a tumor evolves, and that these effects could exert fundamental 
and long-term influences over tumor growth and curability. 
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